Analogously, extensive studies regarding the role of TA-MSCs in building cancer-associated vasculature largely concentrate on pro-angiogenic chemokines or growth factors such as VEGF, IL-6, and the CXCL12/CXCR4 axis [234–236]. This evidence concerns the gene CXCL12 and cancer.